Intramedullary Nails Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Femoral Nails, Tibial Nails, Humeral Nails, and Others), By Material (Stainless Steel, Titanium, and Others), By Application (Proximal Fractures, Distal Fractures, and Shaft Fractures), By End-User (Hospitals, Ambulatory Surgical Centers, and Orthopedic Clinics), and  Region

Intramedullary Nails Market size was valued at US$ 718.5 million in 2023 and is projected to reach US$ 1,131.3 million by 2030 and poised to grow at 6.4% CAGR 2024-2030. Intramedullary nails are orthopedic devices used for the internal fixation of long bone fractures, particularly in the femur, tibia, and humerus. The market encompasses various types of nails designed for specific bones and fracture patterns, along with associated instruments and accessories. The market is driven by the increasing incidence of long bone fractures due to road accidents and sports injuries, the growing geriatric population prone to osteoporotic fractures, and technological advancements in nail design and materials.

However, challenges such as the high cost of procedures and the risk of complications may hinder market growth in some regions. For instance, the World Health Organization estimates that road traffic accidents cause approximately 20 to 50 million non-fatal injuries annually, many of which require orthopedic interventions. Also, approximately 1.19 million people die each year as a result of road traffic crashes.

Intramedullary Nails Market Key Developments:

• On March 26, 2024, announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons.
• On March 7,2023, X-bolt, an emerging innovator of orthopedic devices, announced that its hip fracture solution, the Pro-X1 Trochanteric Nail, had received 510(K) clearance from the U.S. Food and Drug Administration. The Pro-X1 trochanteric nailing system is intended for use in fracture fixation in the femur in adults with osteopenia or osteoporosis.